Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,113,500 | 994,200 | 1,004,300 | 921,000 | 1,034,500 |
| Cost of Goods | 457,700 | 400,400 | 377,600 | 359,100 | 377,900 |
| Gross Profit | 655,800 | 593,800 | 626,700 | 561,900 | 656,600 |
| Operating Expenses | 467,600 | 442,200 | 469,300 | 460,900 | 440,600 |
| Operating Income | 188,900 | 152,000 | 158,000 | 101,100 | 216,900 |
| Other Income | 22,400 | 25,400 | 29,800 | 31,400 | 29,300 |
| Pre-tax Income | 211,300 | 177,400 | 187,800 | 132,500 | 246,200 |
| Income Tax | 59,600 | 42,800 | 44,300 | -13,900 | -10,100 |
| Net Income Continuous | 151,700 | 134,600 | 143,500 | 146,400 | 256,300 |
| Net Income | $151,700 | $134,600 | $143,500 | $146,400 | $256,300 |
| EPS Basic Total Ops | 0.38 | 0.34 | 0.36 | 0.38 | 0.66 |
| EPS Basic Continuous Ops | 0.39 | 0.34 | 0.36 | 0.38 | 0.67 |
| EPS Diluted Total Ops | 0.37 | 0.34 | 0.35 | 0.36 | 0.61 |
| EPS Diluted Continuous Ops | 0.37 | 0.33 | 0.34 | 0.35 | 0.61 |
| EPS Diluted Before Non-Recurring Items | 0.45 | 0.45 | 0.43 | N/A | N/A |
| EBITDA(a) | $246,700 | $207,300 | $210,100 | $153,600 | $269,400 |